Loading...
•
Mar 31, 2024
Elevance Health Q1 2024 Earnings Report
Elevance Health's first quarter results reflected disciplined execution of strategic initiatives, progress in expanding Carelon's capabilities, and increased outlook for full year earnings.
Key Takeaways
Elevance Health reported a 0.9% increase in operating revenue to $42.3 billion for Q1 2024, with diluted EPS up 15.5% to $9.59 and adjusted diluted EPS up 12.5% to $10.64. The company has raised its full-year earnings guidance and is launching a strategic partnership to advance primary care and physician enablement.
Operating revenue increased by 0.9% to $42.3 billion in Q1 2024.
Diluted EPS increased by 15.5% to $9.59, and adjusted diluted EPS increased by 12.5% to $10.64.
Full year diluted EPS and adjusted diluted EPS guidance were raised to greater than $34.05 and $37.20, respectively.
A strategic partnership was launched to advance primary care and physician enablement.
Revenue by Segment
Forward Guidance
Elevance Health expects net income per diluted share to be greater than $34.05 in 2024 and adjusted diluted net income per share to be greater than $37.20.
Positive Outlook
- Increased outlook for full year earnings.
- Strategic partnership to advance primary care and physician enablement.
- Growth in Carelon's capabilities.
- Disciplined execution of strategic initiatives.
- Solid start to the year.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...